Tranexamic acid was found to be effective in preventing hematoma expansion in patients with ICH who were taking NOACs.
Which of the following is a limitation of the TICH-NOAC study?
The TICH-2 trial found that tranexamic acid was unsafe to use in patients with ICH and did not reduce the rate of hematoma expansion in patients with ICH.
